Repression of transforming effect of the HER-2/neu oncogene by the N-terminal domain of the EBNA-1 in breast cancer cells
碩士 === 國防醫學院 === 生物化學研究所 === 87 === The HER-2/neu protooncogene was known to overexpressed in approximately 30% of breast cancer patients and correlated with poor survival. Repression of HER-2/neu overexpression suppressed the malignant phenotype of HER-2/neu-overexpressing cancers. In our previous...
Main Authors: | Feng-Lan Chiu, 邱鳳蘭 |
---|---|
Other Authors: | Ming-Ching Kao |
Format: | Others |
Language: | zh-TW |
Published: |
1999
|
Online Access: | http://ndltd.ncl.edu.tw/handle/69965056556585438479 |
Similar Items
-
Cis-acting element involved in the repression of the HER-2/neu oncogene expression by EBNA-1
by: Lee Ying-Chu, et al.
Published: (1998) -
Establishment of an animal model for liposome-mediated HER-2 oncogene repression by EBNA1
by: Chih-Yu Kuo, et al.
Published: (1999) -
Transcriptional Repression Of HER-2/neu Oncogene By Epstein-Barr Virus Nuclear Antigen-1
by: Way, Tzong-Der, et al.
Published: (1997) -
Transcriptional repression of the HER-2/neu promoter by the tagged N-terminal domain of SV40 large T antigen
by: Yu Yuh-hua, et al.
Published: (2000) -
The N-terminal domain of SV40 large T antigen suppresses the cancer cell metastasis mediated by HER-2/neu oncogene
by: 莊麗瑛
Published: (2000)